Pfizer (PFE) completes the acquisition of NextWave Pharmaceuticals in deal worth an initial...

|About: Pfizer Inc. (PFE)|By:, SA News Editor

Pfizer (PFE) completes the acquisition of NextWave Pharmaceuticals in deal worth an initial $255M plus milestone amounts of up to $425M. With the purchase, Pfizer gains access to Quillivant XR, an FDA-approved treatment for attention deficit hyperactivity disorder (ADHD). (PR)